Dupixent is alleged to cause or accelerate Cutaneous T-cell Lymphoma (“CTCL”) which is a rare and serious white blood cell cancer. Dupixent is prescribed for atopic dermatitis, eczema, asthma and other allergic conditions, including: nasal polyps/chronic sinusitis, eosinophilic esophagitis, prurigo nodularis and chronic obstructive pulmonary disease “(“COPD”). Dupixent acts to mask or accelerat…